Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.04
Delayed Data
As of Feb 24
 -0.04 / -1.92%
Today’s Change
1.99
Today|||52-Week Range
7.85
-35.71%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.08
Today’s open2.07
Day’s range1.99 - 2.09
Volume40,958
Average volume (3 months)51,591
Market cap$5.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.14

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc+0.01+0.68%
CYANCyanotech Corp+0.00+0.12%
BVXVBiondVax Pharmaceuti...+0.35+6.19%
ISRIsoRay Inc+0.00+0.74%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs